Adaptin Bio APTN
OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC

Adaptin Bio (APTN) Assets Average (2023 - 2026)

Adaptin Bio (APTN) posted Assets Average of $662638.0 for Q1 2026, down 17.1% sequentially from $799316.5 in Q4 2025, and down 57.16% YoY from $1.5 million in Q1 2025.

Adaptin Bio (APTN) Assets Average (2023 - 2026) Analysis & Trends

Adaptin Bio has reported Assets Average for 4 years, with the latest figure at $662638.0 in Q1 2026.

  • Quarterly Assets Average fell 57.16% year-over-year to $662638.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $662638.0 (down 57.16% YoY) and the FY2025 annual result came in at $429287.0, up 258.04% from the prior year.
  • Assets Average retreated to $662638.0 in Q1 2026 per APTN's latest filing, from $799316.5 in the prior quarter.
  • Over five years, Assets Average peaked at $2.3 million in Q2 2025 and troughed at $322.0 in Q3 2024.
  • A 4-year average of $609980.0 and a median of $119868.5 in 2024 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2025 and 2026: Assets Average jumped 643295.87% in 2025, then plunged 57.16% in 2026.
  • Over 4 years, Assets Average stood at $380.0 in 2023, then jumped by 31444.34% to $119868.5 in 2024, then surged by 566.83% to $799316.5 in 2025, then fell by 17.1% to $662638.0 in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $662638.0, $799316.5, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 843,784.50
Mar 31, 2026 662,638.00
Dec 31, 2025 799,316.50
Sep 30, 2025 1.32 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 1.55 Mn
Dec 31, 2024 119,868.50
Sep 30, 2024 322.00
Jun 30, 2024 351.00
Mar 31, 2024 380.00
Dec 31, 2023 380.00
Sep 30, 2023 440.00